视网膜静脉阻塞(RVO)是一种常见的高致盲视网膜血管疾病,其影响患者视力主要的并发症为黄斑水肿(ME).以往RVO继发ME的主要治疗方式是激光光凝疗法,但研究发现部分患者经激光治疗后未见明显疗效,并且可能出现一定的危害性.近年来,随着对RVO发病机制的进一步认识和研究,曲安奈德等糖皮质激素玻璃体腔注射或者后Tenon囊下注射,雷珠单抗、贝伐单抗、阿柏西普、康柏西普等抗血管内皮生长因子药物玻璃体腔注射,以及玻璃体视网膜手术治疗逐渐成为RVO继发ME治疗的主要研究方向.现针对RVO继发ME的最新治疗进展进行综述.“,”Retinal vein occlusion (RVO) is a common blinding retinal vascular disease,and the most important complication of vision loss is macular edema (ME).The main treatment for ME secondary to RVO was laser photocoagulation therapy previously,but some researches showed that the laser therapy did not see an obvious curative effection,and might cause certain danger in some patients.In recent years,with the further understanding and research of the pathogenesis of RVO,intravitreal injection or posterior subtenon injection of triamcinolone acetonide and antivascular endothelial growth factor drugs like ranibizumab,bevacizumab,aflibercept,conbercept intravitreal injections,as well as vitreous retinal surgery gradually became the main research directions of ME secondary to RVO.The following to be a review for the advances in the treatment of macular edema secondary to RVO.